Literature DB >> 33341039

Featuring how calcium channels and calmodulin affect glioblastoma behavior. A review article.

Mohammed A Azab1, Abdulraheem Alomari2, Ahmed Y Azzam3.   

Abstract

Glioblastoma (GBM) is considered to be the most aggressive primary brain tumor with an extremely bad prognosis. Recurrence after treatment is a major problem with a survival rate for one year ranging about 39.7%. Ideal outcomes are still difficult to be achieved despite the recent treatment combinations. The ultimate capacity to regrow after resection is considered to be related to the availability of self-regenerating populations of stem cells. We made a literature review interpreting how calcium channels and calcium-regulated proteins mechanistically elaborate glioblastoma virulence in different ways. Calcium channels, and calcium-regulated proteins have shown diverse interconnected roles in shaping different aspects of GBM biology as indicated in some experimental studies. The beneficial prospective of those roles granting GBM different aggressive potentials pose variable applications in targeted therapy whether it is experimental or clinical trials.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CNS; Calcium; Calmodulin; Glioblastoma; Stem cells

Year:  2020        PMID: 33341039     DOI: 10.1016/j.ctarc.2020.100255

Source DB:  PubMed          Journal:  Cancer Treat Res Commun        ISSN: 2468-2942


  3 in total

Review 1.  Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review.

Authors:  Mohammed A Azab; Ahmed Y Azzam
Journal:  Brain Disord       Date:  2021-05-09

Review 2.  Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.

Authors:  Michele Persico; Claudia Abbruzzese; Silvia Matteoni; Paola Matarrese; Anna Maria Campana; Veronica Villani; Andrea Pace; Marco G Paggi
Journal:  Cells       Date:  2022-01-13       Impact factor: 6.600

Review 3.  Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.

Authors:  Elisha Hayden; Holly Holliday; Rebecca Lehmann; Aaminah Khan; Maria Tsoli; Benjamin S Rayner; David S Ziegler
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.